Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

ER+ HER2- Advanced Breast Cancer × AZD9833 × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Breast 1

Conditions

Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Endometrial Neoplasms 1 ER+ HER2- Advanced Breast Cancer 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Diseases 1 Biliary Tract Neoplasms 1 Advanced Breast Cancer 1

Interventions

ribociclib 1 palbociclib 1 abemaciclib 1 AZD9833 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06188520 2026-02-24

CYCAD-1

AstraZeneca

Phase 1/2 Recruiting

BreastGynecologic

ER+ HER2- Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡